These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 3080099

  • 41. Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy.
    Walton KR, Green JR, Reeve J, Wootton R.
    Bone; 1985; 6(1):29-31. PubMed ID: 3922391
    [Abstract] [Full Text] [Related]

  • 42. Treatment of Paget's disease with a diphosphonate (sodium etidronate).
    Smith R, Russell RG.
    Semin Drug Treat; 1972; 2(1):77-81. PubMed ID: 4558759
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
    Hoppé E, Masson C, Laffitte A, Chappard D, Audran M.
    Morphologie; 2012 Aug; 96(313):40-3. PubMed ID: 23022200
    [Abstract] [Full Text] [Related]

  • 45. Quantitative bone histology in Paget's disease of bone: influence of sodium etidronate (EHDP) therapy.
    Khairi MR, Meunier P, Edouard C, Courpron P, Bernard J, DeRosa GP, Johnston CC.
    Calcif Tissue Res; 1977 May; 22 Suppl():355-8. PubMed ID: 410484
    [No Abstract] [Full Text] [Related]

  • 46. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA.
    Henry Ford Hosp Med J; 1983 May; 31(4):244-8. PubMed ID: 6425243
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA, Jung A, Courvoisier B.
    Schweiz Med Wochenschr; 1981 Apr 11; 111(15):518-24. PubMed ID: 6785879
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR, Ibbertson HK, Holdaway IM, Rutland M, King A, Dodd G, Wattie DJ.
    Aust N Z J Med; 1984 Dec 11; 14(6):811-8. PubMed ID: 6442563
    [Abstract] [Full Text] [Related]

  • 52. Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).
    Eyres KS, Marshall P, McCloskey E, Douglas DL, Kanis JA.
    Drug Saf; 1992 Dec 11; 7(2):162-5. PubMed ID: 1605902
    [Abstract] [Full Text] [Related]

  • 53. [Etidronic acid therapy in Paget's disease of bone].
    Holz G, Delling G, Ziegler R.
    Dtsch Med Wochenschr; 1983 Dec 23; 108(51-52):1954-8. PubMed ID: 6418505
    [Abstract] [Full Text] [Related]

  • 54. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ, Bijvoet OL.
    Calcif Tissue Res; 1976 Aug 23; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract] [Full Text] [Related]

  • 55. Etidronate disodium for Paget's disease.
    Med Lett Drugs Ther; 1978 Sep 08; 20(18):78-9. PubMed ID: 99647
    [No Abstract] [Full Text] [Related]

  • 56. Two cases of monostotic Paget's disease: effects of bisphosphonate.
    Hoshiro M, Harada T, Iwai H, Miyatake T, Nishimura A, Ohno Y, Aoki N.
    Endocr J; 2003 Aug 08; 50(4):385-92. PubMed ID: 14599111
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.